Profile data is unavailable for this security.
About the company
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
- Revenue in USD (TTM)6.00k
- Net income in USD-5.96m
- Incorporated1998
- Employees4.00
- LocationCreative Medical Technology Holdings Inc211 E. Osborn Rd.PHOENIX 85012United StatesUSA
- Phone+1 (480) 399-2822
- Websitehttps://creativemedicaltechnology.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ernexa Therapeutics Inc | 1.00k | -18.36m | 5.34m | 6.00 | -- | 1.50 | -- | 5,337.25 | -5.32 | -5.32 | 0.0002 | 0.4548 | 0.0001 | -- | 0.0059 | 166.67 | -264.07 | -187.10 | -2,044.59 | -237.72 | 100.00 | -- | -1,834,000.00 | -3,375.91 | -- | -2.73 | 0.00 | -- | 755.88 | -50.61 | -105.47 | -- | -19.54 | -- |
| CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 5.48m | 0.00 | -- | 2.74 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
| MetaVia Inc | 0.00 | -16.22m | 5.55m | 9.00 | -- | 0.6016 | -- | -- | -13.88 | -13.88 | 0.00 | 2.88 | 0.00 | -- | -- | 0.00 | -87.87 | -99.54 | -167.49 | -140.07 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -121.27 | -- | -48.18 | -- |
| Bullfrog AI Holdings Inc | 116.67k | -6.76m | 5.70m | 9.00 | -- | 2.68 | -- | 48.89 | -0.6936 | -0.6936 | 0.0119 | 0.1866 | 0.0319 | -- | -- | 12,963.33 | -184.34 | -- | -233.50 | -- | 18.76 | -- | -5,770.66 | -- | -- | -- | 0.0278 | -- | -100.00 | -- | -31.42 | -- | -- | -- |
| Aptevo Therapeutics Inc | 0.00 | -27.95m | 6.00m | 37.00 | -- | 0.2651 | -- | -- | -306,220.00 | -306,220.00 | 0.00 | 22.67 | 0.00 | -- | -- | 0.00 | -125.64 | -47.17 | -172.77 | -82.66 | -- | -- | -- | -487.43 | -- | -- | 0.00 | -- | -- | -- | -29.38 | -- | -- | -- |
| Aptorum Group Ltd | -100.00bn | -100.00bn | 6.03m | 1.00 | -- | 0.2348 | -- | -- | -- | -- | -- | 3.15 | -- | -- | -- | -- | -- | -33.06 | -- | -31.53 | -- | 1.65 | -- | -1,009.86 | -- | -- | 0.2079 | -- | -100.00 | -- | -51.09 | -- | -- | -- |
| Calidi Biotherapeutics Inc | 0.00 | -25.62m | 6.04m | 28.00 | -- | 0.8406 | -- | -- | -9.62 | -9.62 | 0.00 | 1.00 | 0.00 | -- | -- | 0.00 | -194.84 | -- | -1,279.90 | -- | -- | -- | -- | -- | -- | -58.24 | 0.1544 | -- | -- | -- | 18.49 | -- | -- | -- |
| enVVeno Medical Corp | 0.00 | -21.97m | 6.13m | 37.00 | -- | 0.1834 | -- | -- | -37.84 | -37.84 | 0.00 | 50.98 | 0.00 | -- | -- | 0.00 | -53.09 | -52.36 | -56.24 | -55.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.22 | -- | -36.69 | -- |
| Creative Medical Technology Holdings Inc | 6.00k | -5.96m | 6.22m | 4.00 | -- | 0.8215 | -- | 1,036.75 | -2.87 | -2.87 | 0.0027 | 2.17 | 0.0009 | 1.10 | -- | 1,500.00 | -93.58 | -83.62 | -98.14 | -- | 60.00 | 62.58 | -99,356.66 | -10,541.10 | 20.70 | -- | 0.00 | -- | 22.22 | -41.85 | -3.91 | -- | -- | -- |
| Brainstorm Cell Therapeutics Inc | 0.00 | -10.85m | 6.44m | 27.00 | -- | -- | -- | -- | -1.50 | -1.50 | 0.00 | -0.6973 | 0.00 | -- | -- | 0.00 | -637.06 | -112.30 | -- | -219.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.39 | -- | -- | -- |
| Aclarion Inc | 67.48k | -7.39m | 6.74m | 6.00 | -- | 0.11 | -- | 99.83 | -1,687.50 | -1,687.50 | 0.1948 | 21.46 | 0.0082 | -- | 2.76 | 11,246.67 | -89.50 | -- | -97.72 | -- | -7.85 | -- | -10,868.49 | -- | -- | -25,428.22 | 0.00 | -- | -39.36 | -- | -43.60 | -- | -- | -- |
| VivoSim Labs Inc | 140.00k | -1.98m | 6.75m | 5.00 | 1.36 | 0.9561 | -- | 48.25 | 1.91 | 1.91 | 0.0226 | 2.71 | 0.017 | -- | 4.59 | 10,769.23 | -24.12 | -51.63 | -34.26 | -56.47 | 98.57 | -- | -1,416.43 | -2,952.99 | -- | -- | 0.00 | -- | 32.11 | -42.01 | 83.04 | -- | -- | -- |
| National Graphite Corp | 0.00 | -1.97m | 6.87m | 0.00 | -- | -- | -- | -- | -0.0221 | -0.0221 | 0.00 | -0.0193 | 0.00 | -- | -- | -- | -11,014.44 | -212.13 | -- | -6,295.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1,432.70 | -- | -- | -- |
| Biomx Inc | 0.00 | -37.38m | 6.96m | 52.00 | -- | -- | -- | -- | -30.62 | -30.62 | 0.00 | 7.43 | 0.00 | -- | -- | 0.00 | -86.77 | -48.34 | -103.85 | -57.24 | -- | -- | -- | -- | -- | -57.02 | 0.00 | -- | -- | -- | 32.26 | -- | -53.03 | -- |
| Pharmacyte Biotech Inc | 0.00 | -8.98m | 7.09m | 2.00 | -- | 0.1334 | -- | -- | -1.32 | -1.32 | 0.00 | 5.38 | 0.00 | -- | -- | 0.00 | -12.74 | 7.21 | -13.51 | 7.54 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 235.53 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to Creative Medical Technology Holdings Inc's reporting currency: US Dollar USD
2.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Geode Capital Management LLCas of 30 Sep 2025 | 23.26k | 0.90% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 20.35k | 0.79% |
| DRW Securities LLCas of 30 Sep 2025 | 15.10k | 0.59% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 5.52k | 0.21% |
| Allworth Financial LPas of 30 Sep 2025 | 4.00k | 0.16% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2025 | 1.13k | 0.04% |
| Edward D. Jones & Co. LP (Investment Management)as of 30 Sep 2025 | 1.00k | 0.04% |
| Strategic Advisers LLCas of 30 Sep 2025 | 200.00 | 0.01% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 2025 | 108.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2025 | 34.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
